文献速递细胞病理与分子病理

唾液腺细针穿刺与米兰系统报告唾液腺细胞病理学更新

Update on Salivary Gland Fine-Needle Aspiration and the Milan System for Reporting Salivary Gland Cytopathology.
PubMed 文献 · Arch Pathol Lab Med · 2024-01-01

本文回顾唾液腺细针穿刺、空心针活检及辅助检测的现状,阐述米兰系统(MSRSGC)的6个诊断分类及各分类的风险恶性和管理建议。MSRSGC旨在改善细胞病理学家与临床医生沟通,已被2021年美国临床肿瘤学会唾液腺癌管理指南认可,其更新基于大量已发表研究数据。

要点

  • MSRSGC包含6个诊断分类,整合唾液腺病变形态异质性与重叠。
  • 每个MSRSGC分类关联风险恶性和管理建议。
  • MSRSGC获2021年ASCO唾液腺癌管理指南认可。

核心结论

  • MSRSGC的主要目标是改善细胞病理学家与治疗临床医生之间的沟通,并促进细胞-组织学对照、质量改进和研究。

研究设计与样本

  • 本文为文献综述结合个人机构经验,回顾唾液腺FNA、空心针活检、辅助研究及MSRSGC的作用。

主要发现

  • MSRSGC包含6个诊断分类,纳入唾液腺非肿瘤、良性和恶性病变的形态异质性和重叠。
  • 每个MSRSGC诊断分类关联风险恶性和管理建议。
  • MSRSGC自实施以来获国际认可,用于提高这一复杂诊断领域的报告标准和一致性。

关键数值与推荐

  • MSRSGC包含6个诊断分类。
  • MSRSGC获2021年美国临床肿瘤学会唾液腺癌管理指南认可。

临床怎么用

  • MSRSGC为唾液腺病变报告提供框架并指导临床管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT.—: Fine-needle aspiration (FNA) is a well-established procedure for the diagnosis and management of salivary gland lesions, despite challenges imposed by salivary gland tumor diversity, complexity, and cytomorphologic overlap. Until recently, the reporting of salivary gland FNA specimens was inconsistent among different institutions throughout the world, leading to diagnostic confusion among pathologists and clinicians. In 2015, an international group of pathologists initiated the development of an evidence-based tiered classification system for reporting salivary gland FNA specimens, the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC). The MSRSGC consists of 6 diagnostic categories, which incorporate the morphologic heterogeneity and overlap among various nonneoplastic, benign, and malignant lesions of the salivary glands. In addition, each MSRSGC diagnostic category is associated with a risk of malignancy and management recommendations. OBJECTIVE.—: To review the current status of salivary gland FNA, core needle biopsies, ancillary studies, and the beneficial role of the MSRSGC in providing a framework for reporting salivary gland lesions and guiding clinical management. DATA SOURCES.—: Literature review and personal institutional experience. CONCLUSIONS.—: The main goal of the MSRSGC is to improve communication between cytopathologists and treating clinicians, while also facilitating cytologic-histologic correlation, quality improvement, and research. Since its implementation, the MSRSGC has gained international acceptance as a tool to improve reporting standards and consistency in this complex diagnostic area, and it has been endorsed by the 2021 American Society of Clinical Oncology management guidelines for salivary gland cancer. The large amount of data from published studies using MSRSGC served as a basis for the recent update of the MSRSGC.

来源:Arch Pathol Lab Med,查看原文。版权归原作者所有。

引用

  1. Pusztaszeri M, Rossi ED, Faquin WC, et al. Update on Salivary Gland Fine-Needle Aspiration and the Milan System for Reporting Salivary Gland Cytopathology. Arch Pathol Lab Med. 2024. PMID: 37226841. doi:10.5858/arpa.2022-0529-RA

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。